World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Welcome to the World Journal of Clinical Oncology

Histologic diagnoses of patients undergoing Whipple’s procedure.

Study design.

Flow chart of eligible patients included in the analysis according to the diagnosis of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or mixed hepatocellular-cholangiocarcinoma on explant pathology (January 1998-July 2019, southern Brazil).

Forest plot for different parameters (demographic, clinical and laboratory) and 30-d mortality outcomes.

Extension for Community Healthcare Outcomes hub and spoke model.

‹ ›

Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast

Featured Articles More >>

Neoadjuvant immunotherapy in non-small-cell lung cancer: Tim... 2022-09-24
Factors predicting upstaging from clinical N0 to pN2a/N3a in... 2022-09-24
Whipple’s pancreaticoduodenectomy at a resource-poor, low-vo... 2022-09-24
Hyperprogression under treatment with immune-checkpoint inhi... 2022-09-24
COVID-19 and oral cancer: Critical viewpoint 2022-08-24

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 1050983

Number of visits today: 469

Number of downloads: 611529

MEMBERSHIP

BPG JOURNALS

GUIDELINES FOR AUTHORS

World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>

2022 Published Issues

9 8 7 6 5 4 3 2 1

Editors-in-Chief

Jian-Hua Mao, BSc, MSc, PhD, Adjunct Professor, Senior Scientist, (E-mail: jhmao@lbl.gov) Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States
Hiten RH Patel, BM BCh, BSc, FRCS, PhD, Professor, Surgical Oncologist, (E-mail: hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway, Tromso 9038, Norway
Stephen Safe, PhD, Professor, (E-mail: ssafe@cvm.tamu.edu) Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77845, United States
Ken H Young, MD, PhD, Chief Physician, Director, Full Professor, (E-mail: ken.young@duke.edu) Hematopathology Division, Duke University Medical Center and Cancer Institute, Durham, NC 27710, United States

Indexing/Abstracting

The WJCO is now abstracted and indexed in PubMed, PubMed Central, Emerging Sources Citation Index (Web of Science), Reference Citation Analysis, China National Knowledge Infrastructure, China Science and Technology Journal Database, and Superstar Journals Database.

Journal Metrics

The 2022 edition of Journal Citation Reports® cites the 2021 Journal Citation Indicator (JCI) for WJCO as 0.35.

ISSN

2218-4333 (online)

Current Issue

Other Issues: Previous | Next | Latest | Archive | Issue 9 (13)

Contents Volume 13 Issue 9 September 24, 2022

Minireviews

Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?

Mo-Xuan Wang, Shu-Yue Gao, Fan Yang, Run-Jia Fan, Qin-Na Yang, Tian-Lan Zhang, Nian-Song Qian, Guang-Hai Dai

World J Clin Oncol 13(9):729-737. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.729

(0) | Open

Retrospective Study

Whipple’s pancreaticoduodenectomy at a resource-poor, low-volume center in Trinidad and Tobago

Shamir O Cawich, Dexter A Thomas, Neil W Pearce, Vijay Naraynsingh

World J Clin Oncol 13(9):738-747. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.738

(0) | Open

Observational Study

Factors predicting upstaging from clinical N0 to pN2a/N3a in breast cancer patients

Goshi Oda, Tsuyoshi Nakagawa, Hiroki Mori, Iichiro Onishi, Tomoyuki Fujioka, Mio Mori, Kazunori Kubota, Ryoichi Hanazawa, Akihiro Hirakawa, Toshiaki Ishikawa, Kentaro Okamoto, Hiroyuki Uetakesszsz

World J Clin Oncol 13(9):748-757. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.748

(0) | Open

Letter to the Editor

Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast

Carlos Aguado, Unai Jiménez Maestre, Xabier Mielgo-Rubio

World J Clin Oncol 13(9):758-761. Published online Sep 24, 2022. doi: 10.5306/wjco.v13.i9.758

(0) | Open